Deciding a preventive migraine treatment: factors, timelines, and approvals.

[William54]

After years of struggling with episodic migraines, my neurologist has suggested we explore preventive treatment options because my acute medications are no longer sufficient and the attacks are starting to significantly impact my work. We've discussed everything from traditional beta-blockers to the newer CGRP inhibitors, but I'm feeling overwhelmed by the choices and concerned about potential side effects and cost. For others who have navigated starting a preventive regimen, what factors did you and your doctor weigh most heavily when selecting a first-line treatment, and how long did it typically take for you to notice a meaningful reduction in frequency or severity? I'm also curious about the real-world experience with insurance approval processes for the newer biologic medications.

[Aubrey27]

You're not alone—many people see meaningful relief within a few months of starting preventive therapy, but it really varies by person and medication. In practice, most clinicians look for a concrete drop in migraine days or severity within 1–3 months; CGRP inhibitors can show early benefits for some, while traditional preventives may take a bit longer or cause side effects that guide switching. The choice of first-line often hinges on comorbidities, tolerability, cost, and patient preference, with a plan to reassess at 6–12 weeks if there’s no clear improvement.